Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]        
Revenues $ 6,964,000 $ 5,051,000 $ 17,932,000 $ 10,585,000
Cost of sales 5,287,000 4,402,000 13,893,000 9,494,000
Gross profit 1,677,000 649,000 4,039,000 1,091,000
Operating expenses:        
Selling and administrative 3,122,000 2,584,000 9,177,000 7,075,000
Research and development 1,523,000 1,527,000 4,624,000 3,888,000
Total operating expenses 4,645,000 4,111,000 13,801,000 10,963,000
Operating loss (2,968,000) (3,462,000) (9,762,000) (9,872,000)
Other income (expense):        
Other income 1,307,000 1,307,000
Interest expense (64,000) (503,000) (618,000) (1,214,000)
Net loss $ (1,725,000) $ (3,965,000) $ (9,073,000) $ (11,086,000)
Net loss per share - basic and diluted $ (0.14) $ (0.78) $ (0.80) $ (2.17)
Weighted average number of common shares outstanding - basic and diluted 12,499,870 5,107,845 11,300,229 5,105,982